More on Arena Pharmaceuticals (ARNA): Q3 beats on a per share basis but comes up short on revenue. Separately, the company announced that it had granted Ildong Pharmaceutical exclusive rights to market and distribute its weight-loss drug Belviq in South Korea, subject to regulatory approval of BELVIQ by the Korea Food and Drug Administration. Shares +1.6% AH.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 4:22PM)
at Benzinga.com (Jan 14, 2015)
at Benzinga.com (Jan 13, 2015)
at Nasdaq.com (Jan 8, 2015)
at CNBC.com (Jan 7, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs